+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 1Year - 70Years
All Genders
ID07314281

Comparing Intravenous Azithromycin and Meropenem Treatments for Drug-Resistant Enteric Fever in Patients Aged 1 to 70 Years

Led by Indus Hospital and Health Network · Updated on 2026-05-08

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the effectiveness of intravenous azithromycin compared to meropenem in treating extensively drug-resistant XDR enteric fever. The study also looks at fever reduction, bacterial eradication, cost-effectiveness, and drug resistance related to these treatments. It is a phase 4 randomized controlled trial sponsored by Indus Hospital and Health Network. Participants will be randomly assigned to one of two groups. The standard care group starts with meropenem 1g intravenously every 8 hours, transitioning to oral azithromycin once stable. The intervention group receives azithromycin intravenously with an initial 1g dose followed by 500mg daily, then switches to oral azithromycin after stability. Both treatments continue intravenously until 24 hours after fever resolution, with a total treatment duration of 14 days. During the study, patients undergo regular monitoring including blood cultures on day 3 and day 7 to check bacterial clearance, and vital signs are checked three times daily. ECG, liver function tests, and clinical assessments are done by day 7 to evaluate progress and any need for treatment changes. Researchers measure fever defervescence and Salmonella Typhi eradication as primary outcomes, alongside monitoring adverse events, hospital stay length, treatment duration, and cost-effectiveness over the course of treatment.

CONDITIONS

Brief Title

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

Research Team

M

muhammad hamid, PharmD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here